Literature DB >> 12014876

Drug-induced lung disease: high-resolution CT and histological findings.

Joanne R Cleverley1, Nicholas J Screaton, Melanie P Hiorns, Julia D A Flint, Nestor L Müller.   

Abstract

AIM: To compare the parenchymal high-resolution computed tomography (HRCT) appearances with histological findings in patients with drug-induced lung disease and to determine the prognostic value of HRCT.
MATERIALS AND METHODS: Drug history, HRCT features, histological findings and outcome at 3 months in 20 patients with drug induced-lung disease were reviewed retrospectively. The HRCT images were assessed for the pattern and distribution of abnormalities and classified as most suggestive of interstitial pneumonitis/fibrosis, diffuse alveolar damage (DAD), organizing pneumonia (OP) reaction, or a hypersensitivity reaction.
RESULTS: On histopathological examination there were eight cases of interstitial pneumonitis/fibrosis, five of DAD, five of OP reactions, one of hypersensitivity reaction and one of pulmonary eosinophilia. The most common abnormalities on HRCT were ground-glass opacities (n = 17), consolidation (n = 14), interlobular septal thickening (n = 15) and centrilobular nodules (n = 8). HRCT interpretation and histological diagnosis were concordant in only nine (45%) of 20 patients. The pattern, distribution, and extent of HRCT abnormalities were of limited prognostic value: all eight patients with histological findings of OP, hypersensitivity reaction, or eosinophilic infiltrate improved on follow-up compared to only five of 13 patients with interstitial pneumonitis/fibrosis or DAD.
CONCLUSION: In many cases of drug-induced lung injury HRCT is of limited value in determining the histological pattern and prognosis. Copyright 2002 The Royal College of Radiologists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014876     DOI: 10.1053/crad.2001.0792

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  34 in total

Review 1.  Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.

Authors:  Fumikazu Sakai; Takeshi Johkoh; Masahiko Kusumoto; Hiroaki Arakawa; Masahiro Takahashi
Journal:  Int J Clin Oncol       Date:  2012-11-10       Impact factor: 3.402

2.  High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data.

Authors:  Sophie Grivaud Martin; Louis-Philippe Kronek; Dominique Valeyre; Nadia Brauner; Pierre-Yves Brillet; Hilario Nunes; Michel W Brauner; Frédérique Réty
Journal:  Eur Radiol       Date:  2009-12-08       Impact factor: 5.315

3.  Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy.

Authors:  S Piciucchi; M Romagnoli; M Chilosi; C Bigliazzi; A Dubini; B Beomonte Zobel; G Gavelli; A Carloni; V Poletti
Journal:  Radiol Med       Date:  2010-12-03       Impact factor: 3.469

4.  Radiologic evaluation of pulmonary injury following carmustine- and cyclophosphamide-based preparative regimen for autologous peripheral blood stem cell transplantation in children.

Authors:  Yu Jin Kim; Woo Sun Kim; Young Hun Choi; Jung-Eun Cheon; Jung Yoon Choi; Hyoung Jin Kang; Ji-Eun Park; Young Jin Ryu; In-One Kim
Journal:  Pediatr Radiol       Date:  2018-08-18

5.  Severe drug-induced interstitial lung disease successfully treated with corticosteroid plus recombinant human soluble thrombomodulin.

Authors:  Satoshi Marumo; Masahiro Shirata; Minoru Sakuramoto; Motonari Fukui
Journal:  BMJ Case Rep       Date:  2014-12-17

Review 6.  Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case.

Authors:  Nusa Matijasic; Aleksandra Bonevski; Visnja Tokic Pivac; Ivan Pavic
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-09-17       Impact factor: 1.349

7.  Fibrotic Lung Toxicity Induced by Hydroxycarbamide.

Authors:  Elena Bargagli; Marco Palazzi; Francesco Perri; Elena Torricelli; Elisabetta Rosi; Alessandra Bindi; Massimo Pistolesi; Luca Voltolini
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

Review 8.  Diagnosis and management of drug-associated interstitial lung disease.

Authors:  N L Müller; D A White; H Jiang; A Gemma
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

9.  Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation.

Authors:  Kyu-won Hwang; Ok Hee Woo; Hwan Seok Yong; Bong Kyung Shin; Jae Jeong Shim; Eun-Young Kang
Journal:  Korean J Radiol       Date:  2008 Mar-Apr       Impact factor: 3.500

Review 10.  Interstitial lung disease associated with drug therapy.

Authors:  P Camus; S Kudoh; M Ebina
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.